Sewage from a secondary hospital in Ribeirão Preto, southeastern Brazil: a source of multidrug-resistant Enterobacteriaceae.
Rafael Nakamura-SilvaRicardo Coelho de SousaRodrigo Yudi FujimotoAndré Pitondo da SilvaPublished in: Environmental monitoring and assessment (2022)
Antimicrobial resistance is one of the severe threats to global health. Hospital sewage can serve as a reservoir for multi-resistant bacteria and promote the spread of antimicrobial resistance. This study aimed to investigate the antimicrobial susceptibility and the pathogenic potential of Enterobacteriaceae isolated from the sewage of a secondary hospital in Ribeirão Preto, a city in southeastern Brazil. The strains were isolated by membrane filtration and identified by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF). The antimicrobial susceptibility profile was performed by disk diffusion. Polymerase chain reaction (PCR) assays were used to detect virulence genes among the strains. Twenty-eight isolates were obtained, with Klebsiella pneumoniae being the predominant species (71.4%, n = 20). All isolates were classified as multidrug-resistant, including four isolates that were non-susceptible to at least 50% of the tested antibiotics. All isolates were also non-susceptible to cefuroxime and sulfonamides antibiotics; however, they were susceptible to norfloxacin, ofloxacin, amikacin, gentamicin, netilmicin, ertapenem, cefazolin, cefaclor, and cefotetan. The virulence genes ycfM, fimH, mrkD, kfu, and entB were detected in several isolates. Our study showed that even in a secondary hospital, without the routine of major surgeries and intensive care admissions, the hospital sewage can harbor a high percentage of multidrug-resistant bacteria with pathogenic potential. This leads to the worrying risk of public health and environmental contamination.
Keyphrases
- multidrug resistant
- antimicrobial resistance
- klebsiella pneumoniae
- drug resistant
- escherichia coli
- gram negative
- acinetobacter baumannii
- public health
- healthcare
- genetic diversity
- acute care
- pseudomonas aeruginosa
- global health
- mass spectrometry
- adverse drug
- human health
- ms ms
- risk assessment
- gene expression
- genome wide
- early onset
- clinical practice
- cystic fibrosis
- urinary tract infection
- water quality
- wastewater treatment
- transcription factor